Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sanofi

SNW2
Current price
52.5 EUR 0 EUR (0.00%)
Last closed 105.08 EUR
ISIN FR0000120578
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Frankfurt Exchange
Capitalization 132 438 333 409 EUR
Yield for 12 month +3.34 %
1Y
3Y
5Y
10Y
15Y
SNW2
21.11.2021 - 28.11.2021

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Address: 46, avenue de la Grande Armée,, Paris, France, 75017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

99.1 EUR

P/E ratio

31.2738

Dividend Yield

3.58 %

Current Year

+43 035 077 289 EUR

Last Year

+45 352 196 959 EUR

Current Quarter

+11 370 772 685 EUR

Last Quarter

+11 108 985 124 EUR

Current Year

+26 476 514 465 EUR

Last Year

+31 671 298 928 EUR

Current Quarter

+7 982 522 231 EUR

Last Quarter

+7 672 773 589 EUR

Key Figures SNW2

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 11 744 469 816 EUR
Operating Margin TTM 14.31 %
PE Ratio 31.2738
Return On Assets TTM 4.16 %
PEG Ratio 0.8679
Return On Equity TTM 5.82 %
Wall Street Target Price 99.1 EUR
Revenue TTM 47 041 827 370 EUR
Book Value 58.06 EUR
Revenue Per Share TTM
Dividend Share 3.76 EUR
Quarterly Revenue Growth YOY 7.5 %
Dividend Yield 3.58 %
Gross Profit TTM 31 671 298 928 EUR
Earnings per share 3.36 EUR
Diluted Eps TTM 3.36 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -22.8 %
Profit Margin 8.95 %

Dividend Analytics SNW2

Champion - 10+ consecutive years of dividend increases

Dividend growth over 5 years

17 %

Continuous growth

24 years

Payout Ratio 5 years average

69 %

Dividend History SNW2

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3.76
Ex Dividend Date 13.05.2024
Forward Annual Dividend Yield 3.58 %
Last Split Factor
Payout Ratio 147.45 %
Last Split Date
Dividend Date

Stock Valuation SNW2

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 31.2738
Forward PE 11.976
Enterprise Value Revenue 3.1543
Price Sales TTM 2.8153
Enterprise Value EBITDA 13.8633
Price Book MRQ 1.8276

Financials SNW2

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SNW2

For 52 weeks

77.51 EUR 105.99 EUR
50 Day MA 96.57 EUR
Shares Short Prior Month
200 Day MA 91.25 EUR
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

P

PGV

224.00 EUR The Progressive Corporation +0.28 (+0.11%)
Detailed analytics
G

GS

471.17 USD Goldman Sachs Group Inc +7.19 (+1.55%)
Detailed analytics
2

2M6

82.00 EUR Medtronic PLC +0.13 (+0.15%)
Detailed analytics
T

TD-PFB

25.00 CAD Toronto Dominion Bank Pref B 0 (0%)
Detailed analytics
SNY

SNY

57.46 USD Sanofi ADR -0.64 (-1.1%)
Detailed analytics